A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma

Clinical trial NCT05370807 · UNKNOWN

Trial details

NCT number: NCT05370807
Sponsor: Universitair Ziekenhuis Brussel
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage III Melanoma Stage IV

Start date: 2022-10-03
Primary completion: 2024-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.